Novartis (NOVN) Q4 revenue, year -round FY24

Spread the love

Office building designed by Frank O. Gary at the Novartis AG Campus in Basel, Switzerland.

Bloomberg | Ghetto images

Swiss pharmaceutical giant Novartis On Friday, they reported better than expected sales in the fourth quarter, but reached their own directions for the year-round section.

The fourth quarter’s net sales increased by 16% at a permanent currency of up to $ 13.2 billion, compared to $ 1295 billion, estimated by analysts in a LSEG survey.

The neighborhood corrected basic operating income is $ 4.86 billion compared to the expected $ 4.23 billion.

In 2024, net sales increased by 12% with a permanent currency of up to $ 50.32 billion, against $ 50.47 billion forecast. The year -round basic operating income increased by 22% to $ 19.5 billion over the estimated estimate of $ 17.02 billion.

Novartis raised its profit instructions in 2024 for the third consecutive quarter in October, saying it expects net sales and major operating income for year -round and basic operating income to grow with “high teenagers” relative to the “medium to high Teens. “

This is a broken news and will be updated soon.

Leave a Reply

Your email address will not be published. Required fields are marked *